Psychiatric Journals

Psychiatry

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Paschos KA et al. – The recent synthesis of orally potent non–peptide micromolecules that can selectively bind to various neuropeptide receptors permits the onset of clinical trials to evaluate their efficacy against depression.

Related Articles

How High-Resolution Basal-State Functional Imaging Can Guide the Development of New Pharmacotherapies for Schizophrenia
Schizophrenia Bulletin, 10/19/09    Relevance Score: 84%

Smoking cessation through the utilization of pharmacotherapy
Expert Review of Respiratory Medicine, 10/14/09    Relevance Score: 83%

Pharmacotherapy of Addictive Disorders
Clinical Neuropharmacology, 10/09/09    Relevance Score: 83%

Cannabinoids as Pharmacotherapies for Neuropathic Pain: From the Bench to the Bedside
Neurotherapeutics, 10/05/09    Relevance Score: 82%

Obstructive sleep apnea in a patient with the Melkersson–Rosenthal syndrome
Sleep and Breathing, 10/30/09    Relevance Score: 80%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address